|
Castillo-Felipe C, Tvarijonaviciute A, Lopez-Arjona M, Pardo-Marin L, Pons-Fuster E, Lopez-Jornet P. Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome. J Clin Med. 2022 Apr 29;11(9):2516. doi: 10.3390/jcm11092516. PubMed PMID: 35566642; PubMed Central PMCID: PMC9101769.
AÑO: 2022; IF: 4.964
|
35566642
|
Lopez-Jornet P, Zamora Lavella C, Pons-Fuster Lopez E, Tvarijonaviciute A. Oral Health Status in Older People with Dementia: A Case-Control Study. J Clin Med. 2021 Jan 27;10(3):477. doi: 10.3390/jcm10030477. PubMed PMID: 33514062; PubMed Central PMCID: PMC7865865.
AÑO: 2021; IF: 4.964
|
|
Garcia-Pola M, Pons-Fuster E, Suarez-Fernandez C, Seoane-Romero J, Romero-Mendez A, Lopez-Jornet P. Role of Artificial Intelligence in the Early Diagnosis of Oral Cancer. A Scoping Review. Cancers (Basel). 2021 Sep 14;13(18):4600. doi: 10.3390/cancers13184600. PubMed PMID: 34572831; PubMed Central PMCID: PMC8467703.
AÑO: 2021; IF: 6.575
|
|
Gimeno L, Gonzalez-Lozano I, Soto-Ramirez MF, Martinez-Sanchez MV, Lopez-Cubillana P, Fuster JL, Martinez-Garcia J, Martinez-Escribano J, Campillo JA, Pons-Fuster E, Ferri B, Lopez-Abad A, Muro M, Minguela A. CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients. Oncoimmunology. 2021 Oct 14;10(1):1986943. doi: 10.1080/2162402X.2021.1986943. eCollection 2021. PubMed PMID: 34676148; PubMed Central PMCID: PMC8525952.
AÑO: 2021; IF: 7.723
|
|
Lopez Jornet P, Hernandez L, Gomez Garcia F, Galera Molero F, Pons-Fuster Lopez E, Tvarijonaviciute A. A Clinical Study on the Efficacy and Tolerability of a New Topical Gel and Toothpaste in Patients with Xerostomia: A Randomized Controlled Trial. J Clin Med. 2021 Nov 29;10(23):5641. doi: 10.3390/jcm10235641. PubMed PMID: 34884343; PubMed Central PMCID: PMC8658424.
AÑO: 2021; IF: 4.964
|